Preventive Care
Feature
What’s Driving the Higher Breast Cancer Death Rate in Black Women?
New research suggests that racial disparities in breast cancer are driven by more than socioeconomic factors.
From the Journals
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
Latest News
Meat Linked to Higher Erectile Dysfunction Risk
NYU urologist discusses impact of a plant-based diet on heart health, prostate cancer, and sexual health.
Conference Coverage
Blood Test Shows Promise for Improving CRC Screening
Researchers evaluate new cfDNA blood-based test’s ability to detect CRC.
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
Conference Coverage
Ovarian Cancer: Another Promising Target for Liquid Biopsy
A test under development “looks very sensitive for detecting ovarian cancer early.”
From the Journals
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Researchers ask 204 oncologists from 37 states for their views on the ethical implications of using AI for cancer care.
From the Journals
Further Support for CRC Screening to Start at Age 45: Meta-Analysis
Across 15 studies, 41,709 adenomas were detected in 150,436 colonoscopies performed for any indication, resulting in a pooled overall ADR of 23.1...
Feature
What to Know About the Next-Gen FIT for CRC Screening
These multitarget approaches take the standard FIT a step further by testing for additional DNA, RNA, or protein biomarkers associated with CRC to...
Conference Coverage
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
Researchers develop signature for pancreatic cancer based on microRNAs and cell-free DNA markers in the blood of patients with the disease.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.